ArticleMedicine2025
Chemotherapy-induced nausea and vomiting symptom experience in patients with non-small-cell lung cancer: A qualitative study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Multi-Disciplinary Approach to the Management of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer.Therapeutics and clinical risk management · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemotherapy-induced nausea and vomiting are one of the most common adverse reactions in cancer patients during chemotherapy, which can lead to metabolic disorders, nutritional deficiencies, loss of appetite, etc, and seriously affect patients' quality of life and treatment compliance. This distressing experience lived through by a large number of people makes it a priority in the improvement of cancer patients and a daily concern for nurses in cancer care units. So Standards for Reporting Qualitative Research Statement Checklist were used to be demonstrated these experiences. This study aims to understand the feelings and experience of chemotherapy-induced nausea and vomiting (CINV) in patients with non-small cell lung cancer. Information obtained through patient interviews using qualitative research methods. Purposive sampling was used to conduct semistructured interviews with 53 patients with non-small-cell lung cancer who met the inclusion and exclusion criteria from March 2021 to May 2021. The data were analyzed by Colaizzi's 7-step analysis. Almost all the patients collected by us had malignant nausea (100%) and vomiting (13.2%) on the first day, peaking at the fifth day. The CINV experience of patients with non-small-cell lung cancer can be summarized into 4 themes: patients have different degrees of CINV, patients have insufficient knowledge about the prevention and treatment of CINV, patients' self-perceived burden is increased, and patients' social support levels are obviously insufficient. The current status of CINV experience in patients with non-small-cell lung cancer is not optimistic, and it should garner the attention and support of society, hospitals, and families. Understanding the patient's perspective may help healthcare professionals design patient-centered health education interventions for patients to learn to manage symptoms of CINV and promote patient recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.